Q2 2021

Filed Aug 18, 2021 · 10-Q · 49 days after period end · 0001654954-21-009195

Q2 2021 · 10-Q

Revenue

$2.00K

— vs Q2 2020

Net Income

-$1.03M

N/M vs Q2 2020

EPS Diluted

-$0.09

N/M vs Q2 2020

Gross Profit$2,000N/M

Operating Income

Same quarter

Metric	Q2 2021	Q2 2020	Q2 2019	Q2 2018
Revenue	$2.00K	$0.00	$1.00K	$8.00K
Net Income	-$1.03M	-$6.75M	-$2.66M	$3.42M
EPS Diluted	-$0.09	-$0.57	-$0.81	$1.24

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR